(10-006) Evaluation of Guideline-Directed Medication Therapy Prescribing of GLP-1 Agonists and SGLT2 Inhibitors in Type Two Diabetic Patients With or at High-Risk of Atherosclerotic Vascular Disease
Wednesday, December 11, 2024
11:00 AM – 12:00 PM
Location: Hall G, Lower Level
Category: Evaluative Study Topic: Drug Information/Drug Use Evaluation
